Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lenalidomide 25mg capsules
0802040Y0AAADAD
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | 1 |
|
Revlimid 10mg capsules
0802040Y0BBABAB
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | 1 |
|
Lenalidomide 10mg capsules
0802040Y0AAABAB
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Lenalidomide 15mg capsules
0802040Y0AAACAC
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Lenalidomide 2.5mg capsules
0802040Y0AAAEAE
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Lenalidomide 20mg capsules
0802040Y0AAAGAG
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Lenalidomide 5mg capsules
0802040Y0AAAAAA
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Lenalidomide 7.5mg capsules
0802040Y0AAAFAF
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revlimid 15mg capsules
0802040Y0BBACAC
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revlimid 2.5mg capsules
0802040Y0BBAEAE
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revlimid 20mg capsules
0802040Y0BBAGAG
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revlimid 25mg capsules
0802040Y0BBADAD
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revlimid 5mg capsules
0802040Y0BBAAAA
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revlimid 7.5mg capsules
0802040Y0BBAFAF
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.